Fresenius Helios has formed a new telemedicine joint-venture that will create an occupational healthcare tool to increase patient flow in Germany. The company exclusively tells HBI it wants to roll out to Spain.
Rates of growth vary dramatically in the for-profit oncology with mature markets with large outpatient radiotherapy sectors in France and Germany being left standing by growth rates in Emerging Markets such as India according to the latest report from HBI Intelligence. Surprisingly, the UK is also growing at 10%.
Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis.
Germany's second-largest private hospital operator Asklepios grew much faster than the other big four - twice as fast in some cases - in 2018. Sources close to the group explain why.
This week we plot three variables showing possible future market potential for for-profit residential elderly care across eleven different countries and three European regions.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
